First Circuit revives Amphastar suit

A lower court misapplied the Noerr-Pennington doctrine in dismissing antitrust claims that two drugmakers conspired to restrict competition for a generic anticoagulant, the US Court of Appeals for the First Circuit held on Monday.

Get unlimited access to all Global Competition Review content